Lonnel Coats's Net Worth
$3.44 Million
Who is Lonnel Coats?
Lonnel Coats has an estimated net worth of $3.44 Million. This is based on reported shares across multiple companies, which include LEXICON PHARMACEUTICALS, INC., Blueprint Medicines Corp, and Verve Therapeutics, Inc..
SEC CIK
Lonnel Coats's CIK is 0001612528
Past Insider Trading and Trends
2017 was Lonnel Coats's most active year for acquiring shares with 31 total transactions. Lonnel Coats's most active month to acquire stocks was the month of January. 2019 was Lonnel Coats's most active year for disposing of shares, totalling 9 transactions. Lonnel Coats's most active month to dispose stocks was the month of January. 2019 saw Lonnel Coats paying a total of $515,531.78 for 884,688 shares, this is the most they've acquired in one year. In 2021 Lonnel Coats cashed out on 247,923 shares for a total of $395,723.22, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
LEXICON PHARMACEUTICALS, INC. (LXRX) Snapshot price: $2.16
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +20.09% | 183.71K |
$2.62 | -$160,792.02 | 1.1M |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
| +10.92% | 90K |
$1.05 | $94,797.00 | 914.36K |
Nov 16
| |||
Form 4
| +1.23% | 10K |
$1.01 | $10,100.00 | 824.36K |
Nov 10
| |||
Form 4
| +1.24% | 10K |
$2.16 | $21,600.00 | 814.36K |
Jun 29
| |||
Form 4
| +2.55% | 20K |
$2.34 | $46,742.00 | 804.36K |
Jun 23 - Jun 26
| |||
Form 4
| +5.37% | 40K |
$2.31 | $92,400.00 | 784.36K |
Jun 22
| |||
Form 4
| +27.02% | 158.36K |
$2.17 | -$110,607.07 | 744.36K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
| +34.18% | 149.29K |
$2.85 | -$136,951.05 | 586K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
| +46.12% | 137.85K |
$7.19 | -$395,723.22 | 436.71K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
| +31.35% | 71.33K |
$2.77 | -$125,536.40 | 298.87K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
| +28.16% | 50K |
$3.10 | $155,000.00 | 227.54K |
Sep 18
| |||
Form 4
| +39.20% | 50K |
$3.13 | $156,403.06 | 177.54K |
Sep 17
| |||
Form 4
| +45.69% | 40K |
$1.35 | $54,028.72 | 127.54K |
Aug 16 - Aug 19
| |||
Form 4
| +50.72% | 29.46K |
$5.51 | -$102,711.91 | 87.54K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
| +35.11% | 15.09K |
$8.53 | -$80,983.82 | 58.08K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
| +30.32% | 10K |
$9.91 | $99,100.00 | 42.98K |
Nov 15
| |||
Form 4
| +1,005.03% | 30K |
$12.54 | $376,336.70 | 32.98K |
Sep 15
| |||
Form 4
| +205.44% | 13.97K |
$16.45 | -$86,494.10 | 20.77K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
|
∞
| 6.8K |
$9.07 | -$36,606.52 | 6.8K |
Feb 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Blueprint Medicines Corp (BPMC) Snapshot price: $74.8
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +30.91% | 2.6K |
—
|
—
| 11.01K |
Jun 21
| |||
Form 4
| +44.74% | 2.6K |
—
|
—
| 8.41K |
Jun 21
| |||
Form 4
| +63.17% | 2.25K |
—
|
—
| 5.81K |
Jun 2
| |||
Form 4
| +171.49% | 2.25K |
—
|
—
| 3.56K |
Jun 24
| |||
Form 4
|
∞
| 1.31K |
—
|
—
| 1.31K |
Jun 19
| |||
Form 4
|
—
|
0
|
$48.71 | -$673,907.18 |
0
|
Aug 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Verve Therapeutics, Inc. (VERV) Snapshot price: $10.985
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||